Friday 6 November 2026 Export RVMD’s income statement to Excel — free account

Revolution Medicines, Inc.

Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022.

Revenue: +1,188.7%
EPS: −18.0%
Free cash flow: −99.1%
Total debt: +322.7%

Quarter to September 2026, against a year earlier

192.35 14.70 +8.27%

Follow RVMD

Alert me

Market cap: $38.1B
P/E: 0.0×
Fwd P/E: −11.9×
Dividend yield: —
F-score: 4/9
Altman Z: 7.73
Beneish M: −4.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Revolution Medicines, Inc. (RVMD) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Revolution Medicines, Inc. (RVMD) trades at a P/B ratio of 16.1×. Over the past ten years it has ranged from 0.0× (March 2020) to 25.4× (June 2026); the current reading is higher than 93% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RVMD/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Revolution Medicines, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RVMD/metrics/pb-ratio">Revolution Medicines, Inc. (RVMD) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2023	2.2×	(18.92%)
FY2022	2.7×	(11.20%)
FY2021	3.0×	(33.55%)
FY2020	4.6×	—
FY2019	0.0×	—
FY2018	0.0×	—

Period	P/B ratio	Change
Sep 2026	18.4×	739.01%
Dec 2023	2.2×	(28.71%)
Jun 2023	3.1×	42.39%
Mar 2023	2.2×	(20.13%)
16 more quarters	Free account

Against its own ten years

Low 0.0× High 25.4×

Ten-year median 3.5×

Current reading's percentile 93

Company	P/B ratio
BNTX BioNTech SE Sponsored ADR compare	1.1×
RPRX Royalty Pharma PLC compare	3.1×
INCY Incyte Corporation compare	4.3×
ROIV Roivant Sciences Ltd. compare	5.4×
GMAB Genmab A/S Sponsored ADR compare	5.5×
ARGX argenex SE compare	6.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	7.5×
RVMD Revolution Medicines, Inc.	16.1×
INSM Insmed, Inc. compare	32.6×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Revolution Medicines, Inc. (RVMD) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on RVMD

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on RVMD

Stockrow Weekly